The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology
Open accessAbstract
Papillomaviridae is a family of small non-enveloped icosahedral viruses with double-stranded circular DNA. More than 200 different human papillomaviruses (HPVs) have been listed so far. Based on epidemiological data, a subgroup of alphapapillomaviruses (alpha HPVs) was referred to as high-risk (HR) HPV types. HR HPVs are the etiological agents of anogenital cancer and a subset of head and neck cancers. The cutaneous HPV types, mainly from beta and gamma genera, are widely present on the surface of the skin in the general population. However, there is growing evidence of an etiological role of betapapillomaviruses (beta HPVs) in non-melanoma skin cancer (NMSC), together with ultraviolet (UV) radiation. Studies performed on mucosal HR HPV types, such as 16 and 18, showed that both oncoproteins E6 and E7 play a key role in cervical cancer by altering pathways involved in the host immune response to establish a persistent infection and by promoting cellular transformation. Continuous expression of E6 and E7 of mucosal HR HPV types is essential to initiate and to maintain the cellular transformation process, whereas expression of E6 and E7 of cutaneous HPV types is not required for the maintenance of the skin cancer phenotype. Beta HPV types appear to play a role in the initiation of skin carcinogenesis, by exacerbating the accumulation of UV radiation-induced DNA breaks and somatic mutations (the hit-and-run mechanism), and they would therefore act as facilitators rather than direct actors in NMSC. In this review, the natural history of HPV infection and the transforming properties of various HPV genera will be described, with a particular focus on describing the state of knowledge about the role of cutaneous HPV types in NMSC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Human papillomavirus oncoproteins: pathways to transformation
Moody, C. A., & Laimins, L. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2886 · Cited by 1,751
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,635
Chaturvedi, A. K., Engels, E. A., Anderson, W. F., & Gillison, M. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1713 · Cited by 1,567
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
Integrated genomic and molecular characterization of cervical cancer
The Cancer Genome Atlas Research Network (2017) · Nature · doi:10.1038/nature21386 · Cited by 1,479
Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains
Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., Crompton, A., Chan, A. C., Anderson, J. M., & Cantley, L. C. (1997) · Science · doi:10.1126/science.275.5296.73 · Cited by 1,385
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
Münger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 964
A skin microRNA promotes differentiation by repressing ‘stemness’
Yi, R., Poy, M. N., Stoffel, M., & Fuchs, E. (2008) · Nature · doi:10.1038/nature06642 · Cited by 790
Näsman, A., Attner, P., Hammarstedt, L., Du, J., Eriksson, M., Giraud, G., Ährlund‐Richter, S., Marklund, L., Romanitan, M., Lindquist, D., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24339 · Cited by 720
Pathogenesis of Human Papillomaviruses in Differentiating Epithelia
Longworth, M. S., & Laimins, L. A. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.2.362-372.2004 · Cited by 677
Protein Composition of Catalytically Active Human Telomerase from Immortal Cells
Cohen, S. B., Graham, M. E., Lovrecz, G. O., Bache, N., Robinson, P. J., & Reddel, R. R. (2007) · Science · doi:10.1126/science.1138596 · Cited by 669
Chellappan, S., Kraus, V. B., Kroger, B., Munger, K., Howley, P. M., Phelps, W. C., & Nevins, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4549 · Cited by 614
Glover, T. W., Berger, C., Coyle, J., & Echo, B. (1984) · Human Genetics · doi:10.1007/bf00272988 · Cited by 602
Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
Egawa, N., Egawa, K., Griffin, H., & Doorbar, J. (2015) · Viruses · doi:10.3390/v7072802 · Cited by 553
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection
Burchell, A. N., Winer, R. L., de Sanjosé, S., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.031 · Cited by 529
Jeon, S., & Lambert, P. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1654 · Cited by 527
Recurrent Respiratory Papillomatosis: A Review
Derkay, C. S., & Wiatrak, B. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e31816a7135 · Cited by 488
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Martinez-Zapien, D., Ruiz, F. X., Poirson, J., Mitschler, A., Ramirez, J., Forster, A., Cousido-Siah, A., Masson, M., Pol, S. V., Podjarny, A., et al. (2016) · Nature · doi:10.1038/nature16481 · Cited by 483
THE PROGRESSION TO CARCINOMA OF VIRUS-INDUCED RABBIT PAPILLOMAS (SHOPE)
Rous, P., & Beard, J. W. (1935) · Journal of Experimental Medicine · doi:10.1084/jem.62.4.523 · Cited by 455
Herfs, M., Yamamoto, Y., Laury, A., Wang, X., Nucci, M. R., McLaughlin-Drubin, M. E., Münger, K., Feldman, S., McKeon, F. D., Xian, W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202684109 · Cited by 437
HPV vaccines – A review of the first decade
Harper, D. M., & DeMars, L. R. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.04.004 · Cited by 429
Antonsson, A., Forslund, O., Ekberg, H., Sterner, G., & Hansson, B. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11636-11641.2000 · Cited by 424
Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., & Galloway, D. A. (1997) · Genes & Development · doi:10.1101/gad.11.16.2090 · Cited by 419
The papillomavirus E7 proteins
Roman, A., & Munger, K. (2013) · Virology · doi:10.1016/j.virol.2013.04.013 · Cited by 409
The Papillomavirus E2 proteins
McBride, A. A. (2013) · Virology · doi:10.1016/j.virol.2013.06.006 · Cited by 403
Peitsaro, P., Johansson, B., & Syrjänen, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.886-891.2002 · Cited by 390
miR-203 represses ‘stemness’ by repressing ΔNp63
Lena, A. M., Shalom-Feuerstein, R., di Val Cervo, P. R., Aberdam, D., Knight, R. A., Melino, G., & Candi, E. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.69 · Cited by 389
Characterization of HPV and host genome interactions in primary head and neck cancers
Parfenov, M., Pedamallu, C. S., Gehlenborg, N., Freeman, S. S., Danilova, L., Bristow, C. A., Lee, S., Hadjipanayis, A. G., Ivanova, E. V., Wilkerson, M. D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416074111 · Cited by 384
Nakagawa, S., & Huibregtse, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8244-8253.2000 · Cited by 382
Jones, D. L., Alani, R. M., & Münger, K. (1997) · Genes & Development · doi:10.1101/gad.11.16.2101 · Cited by 378
Skin cancer in solid organ transplant recipients: Advances in therapy and management
O’Reilly Zwald, F., & Brown, M. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.063 · Cited by 354
Establishment of human papillomavirus infection requires cell cycle progression
Pyeon, D., Pearce, S. M., Lank, S. M., Ahlquist, P., & Lambert, P. F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000318 · Cited by 348
Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling
McNally, K. E., Faulkner, R., Steinberg, F., Gallon, M., Ghai, R., Pim, D., Langton, P., Pearson, N., Danson, C. M., Nägele, H., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3610 · Cited by 346
Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer
Kreimer, A. R., Johansson, M., Waterboer, T., Kaaks, R., Chang-Claude, J., Drogen, D., Tjønneland, A., Overvad, K., Quirós, J. R., González, C. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.2738 · Cited by 335
Howie, H. L., Katzenellenbogen, R. A., & Galloway, D. A. (2009) · Virology · doi:10.1016/j.virol.2008.11.017 · Cited by 332
Current understanding of the mechanism of HPV infection
Schiller, J. T., Day, P. M., & Kines, R. C. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.04.004 · Cited by 332
Barbosa, M. S., Edmonds, C., Fisher, C., Schiller, J. T., Lowy, D. R., & Vousden, K. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08091.x · Cited by 327
Skin cancer in solid organ transplant recipients: Advances in therapy and management
O’Reilly Zwald, F., & Brown, M. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.062 · Cited by 311
Schelhaas, M., Shah, B., Holzer, M., Blattmann, P., Kühling, L., Day, P. M., Schiller, J. T., & Helenius, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002657 · Cited by 295
Kines, R. C., Thompson, C. D., Lowy, D. R., Schiller, J. T., & Day, P. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908502106 · Cited by 293
Orth, G., Jablonska, S., Favre, M., Croissant, O., Jarzabek-Chorzelska, M., & Rzesa, G. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.3.1537 · Cited by 293
HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis
Mirabello, L., Yeager, M., Yu, K., Clifford, G. M., Xiao, Y., Zhu, B., Cullen, M., Boland, J. F., Wentzensen, N., Nelson, C. W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.001 · Cited by 289
Identification of a novel nuclear domain.
Ascoli, C. A., & Maul, G. G. (1991) · The Journal of cell biology · doi:10.1083/jcb.112.5.785 · Cited by 285
Butz, K., Ristriani, T., Hengstermann, A., Denk, C., Scheffner, M., & Hoppe-Seyler, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206894 · Cited by 283
Zimmermann, H., Degenkolbe, R., Bernard, H.-U., & O’Connor, M. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6209-6219.1999 · Cited by 282
Gardiol, D., Kühne, C., Glaunsinger, B., Lee, S. S., Javier, R., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202920 · Cited by 277
Hummel, M., Hudson, J. B., & Laimins, L. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.6070-6080.1992 · Cited by 271
Lee, S. S., Glaunsinger, B., Mantovani, F., Banks, L., & Javier, R. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9680-9693.2000 · Cited by 268
Human Papillomavirus-DNA Loads in Actinic Keratoses Exceed those in Non-Melanoma Skin Cancers
Weissenborn, S. J., Nindl, I., Purdie, K., Harwood, C., Proby, C., Breuer, J., Majewski, S., Pfister, H., & Wieland, U. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23733.x · Cited by 265
Huh, K., Zhou, X., Hayakawa, H., Cho, J.-Y., Libermann, T. A., Jin, J., Wade Harper, J., & Munger, K. (2007) · Journal of Virology · doi:10.1128/jvi.00881-07 · Cited by 259
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors
Thorland, E. C., Myers, S. L., Gostout, B. S., & Smith, D. I. (2003) · Oncogene · doi:10.1038/sj.onc.1206170 · Cited by 248
Day, P. M., Baker, C. C., Lowy, D. R., & Schiller, J. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404229101 · Cited by 245
The serological response to papillomaviruses
Dillner, J. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0146 · Cited by 231
HIV Infection Status, Immunodeficiency, and the Incidence of Non-Melanoma Skin Cancer
Silverberg, M. J., Leyden, W., Warton, E. M., Quesenberry, C. P., Engels, E. A., & Asgari, M. M. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs529 · Cited by 229
General Acquisition of Human Papillomavirus Infections of Skin Occurs in Early Infancy
Antonsson, A., Karanfilovska, S., Lindqvist, P. G., & Hansson, B. G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2509-2514.2003 · Cited by 225
Perspectives for therapeutic HPV vaccine development
Yang, A., Farmer, E., Wu, T. C., & Hung, C.-F. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0293-9 · Cited by 224
Therapeutic vaccines for high-risk HPV-associated diseases
Chabeda, A., Yanez, R. J. R., Lamprecht, R., Meyers, A. E., Rybicki, E. P., & Hitzeroth, I. I. (2018) · Papillomavirus Research · doi:10.1016/j.pvr.2017.12.006 · Cited by 218
Fehrmann, F., Klumpp, D. J., & Laimins, L. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.2819-2831.2003 · Cited by 202
Thomas, J. T., Hubert, W. G., Ruesch, M. N., & Laimins, L. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8449 · Cited by 199
Bravo, I. G., & Félez-Sánchez, M. (2015) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eov003 · Cited by 199
Beta genus papillomaviruses and skin cancer
Howley, P. M., & Pfister, H. J. (2015) · Virology · doi:10.1016/j.virol.2015.02.004 · Cited by 193
Lazarczyk, M., Pons, C., Mendoza, J.-A., Cassonnet, P., Jacob, Y., & Favre, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071311 · Cited by 190
Filippova, M., Song, H., Connolly, J. L., Dermody, T. S., & Duerksen-Hughes, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200113200 · Cited by 186
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4918 · Cited by 182
Thomas, M. C., & Chiang, C.-M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.016 · Cited by 178
Huh, K.-W., DeMasi, J., Ogawa, H., Nakatani, Y., Howley, P. M., & Münger, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505337102 · Cited by 176
Maglennon, G. A., McIntosh, P., & Doorbar, J. (2011) · Virology · doi:10.1016/j.virol.2011.03.019 · Cited by 175
McPhillips, M. G., Oliveira, J. G., Spindler, J. E., Mitra, R., & McBride, A. A. (2006) · Journal of Virology · doi:10.1128/jvi.01105-06 · Cited by 172
Culp, T. D., Budgeon, L. R., Marinkovich, M. P., Meneguzzi, G., & Christensen, N. D. (2006) · Journal of Virology · doi:10.1128/jvi.00724-06 · Cited by 171
Biology of Human Papillomavirus Infections in Head and Neck Carcinogenesis
Rautava, J., & Syrjänen, S. (2012) · Head and Neck Pathology · doi:10.1007/s12105-012-0367-2 · Cited by 169
Human Papillomavirus Type 16 Entry: Retrograde Cell Surface Transport along Actin-Rich Protrusions
Schelhaas, M., Ewers, H., Rajamäki, M.-L., Day, P. M., Schiller, J. T., & Helenius, A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000148 · Cited by 168
Thomas, M., & Banks, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-6-1513 · Cited by 166
The biology of beta human papillomaviruses
Tommasino, M. (2016) · Virus Research · doi:10.1016/j.virusres.2016.11.013 · Cited by 166
Seroprevalence of 34 Human Papillomavirus Types in the German General Population
Michael, K. M., Waterboer, T., Sehr, P., Rother, A., Reidel, U., Boeing, H., Bravo, I. G., Schlehofer, J., Gärtner, B. C., & Pawlita, M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000091 · Cited by 165
MAGI-1 Interacts with β-Catenin and Is Associated with Cell–Cell Adhesion Structures
Dobrosotskaya, I. Y., & James, G. L. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2471 · Cited by 162
Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States)
Giuliano, A. R., Sedjo, R. L., Roe, D. J., Harris, R. B., Baldwin, S. B., Papenfuss, M. R., Abrahamsen, M. E., & Inserra, P. F. (2002) · Cancer Causes & Control · doi:10.1023/a:1020668232219 · Cited by 161
Agalliu, I., Gapstur, S., Chen, Z., Wang, T., Anderson, R. L., Teras, L., Kreimer, A. R., Hayes, R. B., Freedman, N. D., & Burk, R. D. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5504 · Cited by 161
Kotelevets, L., van Hengel, J., Bruyneel, E. A., Mareel, M. M. K., Roy, F. M. V., & Chastre, E. (2004) · The FASEB Journal · doi:10.1096/fj.04-1942fje · Cited by 158
Aydin, I., Weber, S., Snijder, B., Ventayol, P. S., Kühbacher, A., Becker, M., Day, P. M., Schiller, J. T., Kann, M., Pelkmans, L., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004162 · Cited by 156
Arron, S. T., Ruby, J. G., Dybbro, E., Ganem, D., & DeRisi, J. L. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.91 · Cited by 152
HPV16 genetic variation and the development of cervical cancer worldwide
the IARC HPV Variant Study Group, Cornet, I., Gheit, T., Iannacone, M. R., Vignat, J., Sylla, B. S., Mistro, A. D., Franceschi, S., Tommasino, M., & Clifford, G. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.508 · Cited by 150
Self-citationFilippova, M., Parkhurst, L., & Duerksen-Hughes, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401172200 · Cited by 149
Bavinck, J. N. B., Neale, R. Ε., ABENI, D. D., Euvrard, S., Green, A. C., Harwood, C. A., de Koning, M. N. C., Naldi, L., Nindl, I., Pawlita, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0352 · Cited by 145
Nulton, T. J., Olex, A. L., Dozmorov, M. G., Morgan, I. M., & Windle, B. (2017) · Oncotarget · doi:10.18632/oncotarget.15179 · Cited by 145
Hong, A., Grulich, A. E., Jones, D., Lee, C. S., Garland, S. M., Dobbins, T., Clark, J. R., Harnett, G. B., Milross, C., O’Brien, C. J., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.098 · Cited by 144
The human CIB1–EVER1–EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses
de Jong, S. J., Créquer-Grandhomme, A., Matos, I., Hum, D., Gunasekharan, V., Lorenzo, L., Jabot‐Hanin, F., Imahorn, E., Arias, A. A., Vahidnezhad, H., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170308 · Cited by 141
Cutaneous wart-associated HPV types: Prevalence and relation with patient characteristics
Bruggink, S. C., de Koning, M. N. C., Gussekloo, J., Egberts, P. F., ter Schegget, J., Feltkamp, M. C. W., Bavinck, J. N. B., Quint, W. G. V., Assendelft, W. J., & Eekhof, J. A. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.07.014 · Cited by 139
Schmitt, A., Harry, J. B., Rapp, B., Wettstein, F. O., & Iftner, T. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7051-7059.1994 · Cited by 139
Biological activity of probable/possible high‐risk human papillomavirus types in cervical cancer
Halec, G., Schmitt, M., Dondog, B., Sharkhuu, E., Wentzensen, N., Gheit, T., Tommasino, M., Kommoss, F., Bosch, F. X., Franceschi, S., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27605 · Cited by 137
Self-citationCommon Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
Wang, S., González, P., Yu, K. F., Porras, C., Li, Q., Safaeian, M., Rodríguez, A. C., Sherman, M. E., Bratti, C., SCHIFFMAN, M. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008667 · Cited by 135
HPV 5 and 8 E6 Abrogate ATR Activity Resulting in Increased Persistence of UVB Induced DNA Damage
Wallace, N. A., Robinson, K. L., Howie, H. L., & Galloway, D. A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002807 · Cited by 134
Brimer, N., Lyons, C., Wallberg, A. E., & Vande Pol, S. B. (2012) · Oncogene · doi:10.1038/onc.2011.589 · Cited by 133
Betapapillomaviruses frequently persist in the skin of healthy individuals
de Koning, M. N. C., Struijk, L., Bavinck, J. N. B., Kleter, B., ter Schegget, J., Quint, W. G. V., & Feltkamp, M. C. W. (2007) · Journal of General Virology · doi:10.1099/vir.0.82732-0 · Cited by 133
Human Papillomavirus L2 Facilitates Viral Escape from Late Endosomes via Sorting Nexin 17
Bergant Marušič, M., Ozbun, M. A., Campos, S. K., Myers, M. P., & Banks, L. (2012) · Traffic · doi:10.1111/j.1600-0854.2011.01320.x · Cited by 130
Cancer associated human papillomaviruses
McLaughlin-Drubin, M. E., Meyers, J. M., & Münger, K. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.05.004 · Cited by 130
Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide
Chen, A. A., Gheit, T., Franceschi, S., Tommasino, M., & Clifford, G. M. (2015) · Journal of Virology · doi:10.1128/jvi.01747-15 · Cited by 130
Self-citationNon-Random Integration of the HPV Genome in Cervical Cancer
Schmitz, M., Driesch, C., Jansen, L., Runnebaum, I. B., & Dürst, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039632 · Cited by 129
Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas
Xu, B., Chotewutmontri, S., Wolf, S., Klos, U., Schmitz, M., Dürst, M., & Schwarz, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066693 · Cited by 126
Lee, C., & Laimins, L. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12366-12377.2004 · Cited by 125
Genther Williams, S. M., Disbrow, G. L., Schlegel, R., Lee, D., Threadgill, D. W., & Lambert, P. F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0083 · Cited by 125
Quantifying the Phylodynamic Forces Driving Papillomavirus Evolution
Gottschling, M., Göker, M., Stamatakis, A., Bininda‐Emonds, O. R. P., Nindl, I., & Bravo, I. G. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr030 · Cited by 125
Popa, A., Zhang, W., Harrison, M. S., Goodner, K., Kazakov, T., Goodwin, E. C., Lipovsky, A. I., Burd, C. G., & DiMaio, D. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004699 · Cited by 123
Skin human papillomavirus type 38 alters p53 functions by accumulation of ΔNp73
Accardi, R., Dong, W., Smet, A., Cui, R., Hautefeuille, A. H., Gabet, A., Sylla, B. S., Gissmann, L., Hainaut, P. L., & Tommasino, M. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400615 · Cited by 123
Zhang, Y., Dasgupta, J., Ma, R. Z., Banks, L., Thomas, M., & Chen, X. S. (2007) · Journal of Virology · doi:10.1128/jvi.02044-06 · Cited by 123
Interaction of the Papillomavirus E2 Protein with Mitotic Chromosomes
Bastien, N., & McBride, A. A. (2000) · Virology · doi:10.1006/viro.2000.0265 · Cited by 122
Viarisio, D., Müller‐Decker, K., Accardi, R., Robitaille, A., Dürst, M., Beer, K., Jansen, L., Flechtenmacher, C., Bozza, M., Harbottle, R. P., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006783 · Cited by 122
Banks, L., Edmonds, C., & Vousden, K. H. (1990) · PubMed · Cited by 120
Human papillomaviruses and cancer
Haedicke, J., & Iftner, T. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.004 · Cited by 120
Wetherill, L. F., Holmes, K. K., Verow, M., Müller, M., Howell, G. J., Harris, M., Fishwick, C. W. G., Stonehouse, N. J., Foster, R., Blair, G. E., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06243-11 · Cited by 119
Parish, J. L., Bean, A., Park, R. B., & Androphy, E. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.005 · Cited by 118
The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells
Parish, J. L., Rosa, J., Wang, X., Lahti, J. M., Doxsey, S., & Androphy, E. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03262 · Cited by 117
Bienkowska‐Haba, M., Williams, C., Kim, S. M., Garcea, R. L., & Sapp, M. J. (2012) · Journal of Virology · doi:10.1128/jvi.00980-12 · Cited by 116
Human papillomavirus type 16 E7 oncoprotein associates with E2F6
McLaughlin-Drubin, M. E., Huh, K.-W., & Münger, K. (2008) · Journal of Virology · doi:10.1128/jvi.00579-08 · Cited by 116
López-Bueno, A., Mavian, C. N., Labella, A. M., Castro, D., Borrego, J. J., Alcamí, A., & Alejo, A. (2016) · Journal of Virology · doi:10.1128/jvi.01369-16 · Cited by 115
Bravo, I. G., & Alonso, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13613-13626.2004 · Cited by 113
Involvement of NF- B and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein
Kim, S.-H., Oh, J., No, J. H., Bang, Y.-J., Juhnn, Y., & Song, Y. S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp066 · Cited by 112
The clinical importance of understanding the evolution of papillomaviruses
Bravo, I. G., de Sanjosé, S., & Gottschling, M. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.07.008 · Cited by 111
Schmitt, A. P., Rochat, A., Zeltner, R., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1912-1922.1996 · Cited by 107
Interaction of the HPV E7 proteins with the pCAF acetyltransferase
Avvakumov, N., Torchia, J., & Mymryk, J. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206562 · Cited by 107
Cerqueira, C., Ventayol, P. S., Vogeley, C., & Schelhaas, M. (2015) · Journal of Virology · doi:10.1128/jvi.00234-15 · Cited by 107
Kranjec, C., & Banks, L. (2010) · Journal of Virology · doi:10.1128/jvi.01756-10 · Cited by 106
Olthof, N. C., Speel, E. M., Kolligs, J., Haesevoets, A. M., Henfling, M. E. R., Ramaekers, F. C. S., Preuss, S. F., Drebber, U., Wieland, U., Silling, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088718 · Cited by 105
Papillomavirus Genomes Associate with BRD4 to Replicate at Fragile Sites in the Host Genome
Jang, M. K., Shen, K., & McBride, A. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004117 · Cited by 104
Filippova, M., Johnson, M. M., Bautista, M., Filippov, V., Fodor, N., Tungteakkhun, S. S., Williams, K., & Duerksen-Hughes, P. J. (2007) · Journal of Virology · doi:10.1128/jvi.01924-06 · Cited by 103
Maucort‐Boulch, D., Plummer, M., Castle, P. E., Demuth, F., Safaeian, M., Wheeler, C. M., & Schiffman, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24752 · Cited by 103
Cell polarity proteins: Common targets for tumorigenic human viruses
Javier, R. T. (2008) · Oncogene · doi:10.1038/onc.2008.352 · Cited by 102
Reorganization of Nuclear Domain 10 Induced by Papillomavirus Capsid Protein L2
Florin, L., Schäfer, F., Sotlar, K., Streeck, R. E., & Sapp, M. J. (2002) · Virology · doi:10.1006/viro.2002.1360 · Cited by 101
High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation
White, E. A., Münger, K., & Howley, P. M. (2016) · mBio · doi:10.1128/mbio.01530-16 · Cited by 101
Vici, P., Pizzuti, L., Mariani, L., Zampa, G., Santini, D., Lauro, L. D., Gamucci, T., Natoli, C., Marchetti, P., Barba, M., et al. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1176533 · Cited by 100
The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer
Guo, T. W., Eisele, D. W., & Fakhry, C. (2016) · Cancer · doi:10.1002/cncr.29992 · Cited by 100
A risk for non-sexual transmission of human papillomavirus?
Ryndock, E. J., & Meyers, C. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.959497 · Cited by 99
Akgũl, B., García‐Escudero, R., Ghali, L. R., Pfister, H., Fuchs, P. G., Navsaria, H. A., & Storey, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1952 · Cited by 99
Beta-HPV 5 and 8 E6 Promote p300 Degradation by Blocking AKT/p300 Association
Howie, H. L., Koop, J. I., Weese, J., Robinson, K. L., Wipf, G. C., Kim, L., & Galloway, D. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002211 · Cited by 97
Analyses of human papillomavirus genotypes and viral loads in anogenital warts
Ball, S. L. R., Winder, D. M., Vaughan, K., Hanna, N., Lévy, J., Sterling, J. C., Stanley, M., & Goon, P. K. C. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22111 · Cited by 94
Pim, D., Storey, A., Thomas, M., Massimi, P., & Banks, L. (1994) · PubMed · Cited by 94
The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA
Stöppler, M. C., Straight, S. W., Tsao, G., Schlegel, R., & Mccance, D. J. (1996) · Virology · doi:10.1006/viro.1996.0475 · Cited by 93
Rubio, I., Seitz, H., Canali, E., Sehr, P. A., Bolchi, A., Tommasino, M., Ottonello, S., & Müller, M. (2010) · Virology · doi:10.1016/j.virol.2010.10.017 · Cited by 93
Collins, S. I., Constandinou-Williams, C., Wen, K., Young, L. S., Roberts, S., Murray, P. G., & Woodman, C. B. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3099 · Cited by 93
Cornet, I., Bouvard, V., Campo, M. S., Thomas, M., Banks, L., Gissmann, L., Lamartine, J., Sylla, B. S., Accardi, R., & Tommasino, M. (2011) · Journal of Virology · doi:10.1128/jvi.06579-11 · Cited by 92
Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F., & Iftner, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1307 · Cited by 92
Accardi, R., & Gheit, T. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.08.008 · Cited by 92
Self-citationMeyers, J. M., Spangle, J. M., & Münger, K. (2013) · Journal of Virology · doi:10.1128/jvi.02527-12 · Cited by 91
Jansma, A. L., Martinez‐Yamout, M. A., Liao, R., Sun, P., Dyson, H. J., & Wright, P. E. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.10.021 · Cited by 90
Valle, G. F., & Banks, L. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-5-1239 · Cited by 90
Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency
Pastrana, D. V., Peretti, A., Welch, N. L., Borgogna, C., Olivero, C., Badolato, R., Notarangelo, L. D., Gariglio, M., FitzGerald, P. C., MCINTOSH, C. E., et al. (2018) · mSphere · doi:10.1128/mspheredirect.00645-18 · Cited by 90
Bavinck, J. N. B., Feltkamp, M. C. W., Green, A. C., Fiocco, M. F., Euvrard, S., Harwood, C. A., Nasir, S., Thomson, J., Proby, C. M., Naldi, L., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14537 · Cited by 89
Bedard, K., Underbrink, M. P., Howie, H. L., & Galloway, D. A. (2008) · Journal of Virology · doi:10.1128/jvi.01818-07 · Cited by 88
Gheit, T., Cornet, I., Clifford, G. M., Iftner, T., Munk, C., Tommasino, M., & Kjær, S. K. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1187 · Cited by 86
Self-citationZhang, B., Spandau, D. F., & Roman, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.220-231.2002 · Cited by 85
Massimi, P., Pim, D., Storey, A., & Banks, L. (1996) · PubMed · Cited by 85
Gray, E. H., Pett, M. R., Ward, D. M., Winder, D. M., Stanley, M., Roberts, I., Scarpini, C. G., & Coleman, N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3335 · Cited by 84
Leverrier, S., Bergamaschi, D., Ghali, L. R., Ola, A., Warnes, G., Akgũl, B., Blight, K., García‐Escudero, R., Penna, A., Eddaoudi, A., et al. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0004-1 · Cited by 83
Boon, S. S., & Banks, L. (2012) · Journal of Virology · doi:10.1128/jvi.02074-12 · Cited by 82
Sp100 Provides Intrinsic Immunity against Human Papillomavirus Infection
Stepp, W. H., Meyers, J. M., & McBride, A. A. (2013) · mBio · doi:10.1128/mbio.00845-13 · Cited by 82
Effects of human papillomavirus type 16 oncoproteins on survivin gene expression
Borbély, Á., Murvai, M., Kónya, J., Beck, Z., Gergely, L., Li, F., & Veress, G. (2006) · Journal of General Virology · doi:10.1099/vir.0.81067-0 · Cited by 81
Oh, J.-M., Kim, S.-H., Cho, E.-A., Song, Y.-S., Kim, W.-H., & Juhnn, Y.-S. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp318 · Cited by 80
Pentland, I., Campos-León, K., Cotic, M., Davies, K.-J., Wood, C. D., Groves, I. J., Burley, M., Coleman, N., Stockton, J., Noyvert, B., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005752 · Cited by 79
Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions
Klein, C., Gonzalez, D., Samwel, K., Kahesa, C., Mwaiselage, J. D., Aluthge, N. D., Fernando, S. C., West, J. T., Wood, C. A., & Angeletti, P. C. (2019) · mBio · doi:10.1128/mbio.02785-18 · Cited by 79
Lace, M. J., Anson, J. R., Thomas, G. S., Turek, L. P., & Haugen, T. H. (2008) · Journal of Virology · doi:10.1128/jvi.01481-08 · Cited by 78
Katzenellenbogen, R. A., Egelkrout, E. M., Vliet-Gregg, P., Gewin, L. C., Gafken, P. R., & Galloway, D. A. (2007) · Journal of Virology · doi:10.1128/jvi.02007-06 · Cited by 78
The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7
Szalmás, A., Tomaić, V., Basukala, O., Massimi, P., Mittal, S., Kónya, J., & Banks, L. (2017) · Journal of Virology · doi:10.1128/jvi.00057-17 · Cited by 78
Association between hTERT activation by HPV E6 proteins and oncogenic risk
Doorslaer, K. V., & Burk, R. D. (2012) · Virology · doi:10.1016/j.virol.2012.08.006 · Cited by 77
Favre-Bonvin, A., Reynaud, C., Kretz‐Remy, C., & Jalinot, P. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4229-4237.2005 · Cited by 77
Towards quality and order in human papillomavirus research
Mühr, L. S. A., Eklund, C., & Dillner, J. (2018) · Virology · doi:10.1016/j.virol.2018.04.003 · Cited by 76
The Effects of Signal Erosion and Core Genome Reduction on the Identification of Diagnostic Markers
Sahl, J. W., Vazquez, A. J., Hall, C. M., Busch, J. D., Tuanyok, A., Mayo, M. J., Schupp, J. M., Lummis, M., Pearson, T., Shippy, K., et al. (2016) · mBio · doi:10.1128/mbio.00846-16 · Cited by 75
p600, a unique protein required for membrane morphogenesis and cell survival
Nakatani, Y., Konishi, H., Vassilev, A. P., Kurooka, H., Ishiguro, K., Sawada, J., Ikura, T., Korsmeyer, S. J., Qin, J., & Herlitz, A. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507458102 · Cited by 73
Chen, Z., SCHIFFMAN, M. H., Herrero, R., DeSalle, R., & Burk, R. D. (2006) · Virology · doi:10.1016/j.virol.2006.10.022 · Cited by 73
E6AP-Dependent Degradation of DLG4/PSD95 by High-Risk Human Papillomavirus Type 18 E6 Protein
Handa, K., Yugawa, T., Narisawa‐Saito, M., Ohno, S.-I., Fujita, M., & Kiyono, T. (2006) · Journal of Virology · doi:10.1128/jvi.01712-06 · Cited by 73
Human papillomavirus mediated inhibition of DNA damage sensing and repair drives skin carcinogenesis
Hufbauer, M., Cooke, J. C., van der Horst, G. T. J., Pfister, H., Storey, A., & Akgũl, B. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0453-7 · Cited by 72
Pim, D., Broniarczyk, J. K., Bergant, M., Playford, M. P., & Banks, L. (2015) · Journal of Virology · doi:10.1128/jvi.01499-15 · Cited by 72
Role of inflammasome genetics in susceptibility to HPV infection and cervical cancer development
Pontillo, A., Choque, P. N. B., Leal, V. N. C., de Lima, S. C., de Souza, P. R. E., & Crovella, S. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24514 · Cited by 72
Thomas, M., Myers, M. P., Massimi, P., Guarnaccia, C., & Banks, L. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005766 · Cited by 72
The interplay of UV and cutaneous papillomavirus infection in skin cancer development
Hasche, D., Stephan, S., Braspenning‐Wesch, I., Mikulec, J., Niebler, M., Gröne, H., Flechtenmacher, C., Akgũl, B., Rösl, F., & Vinzón, S. E. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006723 · Cited by 70
Iannacone, M. R., Gheit, T., Pfister, H., Giuliano, A. R., Messina, J. L., Fenske, N. A., Cherpelis, B. S., Sondak, V. K., Roetzheim, R. G., Silling, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28552 · Cited by 69
Self-citationZhang, R., Shen, C., Zhao, L., Wang, J., McCrae, M. A., Chen, X., & Lu, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29872 · Cited by 69
Kühne, C., Gardiol, D., Guarnaccia, C., Amenitsch, H. W., & Banks, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203988 · Cited by 69
Accardi, R., Rubino, R., Scalise, M., Gheit, T., Shahzad, N., Thomas, M., Banks, L., Indiveri, C., Sylla, B. S., Cardone, R. A., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00114-11 · Cited by 68
Self-citationNFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes
Xu, M., Luo, W., Elzi, D. J., Grandori, C., & Galloway, D. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01969-07 · Cited by 68
Gauson, E. J., Donaldson, M., Dornan, E. S., Wang, X., Bristol, M. L., Bodily, J. M., & Morgan, I. M. (2015) · Journal of Virology · doi:10.1128/jvi.00335-15 · Cited by 67
Shin, M.-K., Balsitis, S. J., Brake, T., & Lambert, P. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3711 · Cited by 67
Human papillomavirus type 197 is commonly present in skin tumors
Mühr, L. S. A., Hultin, E., Bzhalava, D., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29325 · Cited by 65
E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis
Wolyniec, K., Shortt, J., de Stanchina, E., Levav-Cohen, Y., Alsheich-Bartok, O., Louria‐Hayon, I., Corneille, V., Kumar, B., Woods, S. J., Opat, S., et al. (2012) · Blood · doi:10.1182/blood-2011-10-387647 · Cited by 65
DiGiuseppe, S., Bienkowska‐Haba, M., Guion, L. G. M., Keiffer, T. R., & Sapp, M. J. (2017) · Journal of Virology · doi:10.1128/jvi.00537-17 · Cited by 65
James, M. A., Lee, J. H., & Klingelhutz, A. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22064 · Cited by 64
Human papillomaviruses and carcinogenesis: well-established and novel models
Viarisio, D., Gissmann, L., & Tommasino, M. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.07.014 · Cited by 64
Nobre, R. J., Herráez-Hernández, E., Fei, J.-W., Langbein, L., Kaden, S., Gröne, H., & de Villiers, E. (2009) · Journal of Virology · doi:10.1128/jvi.02490-08 · Cited by 62
Molecular Concepts of Virus Infections Causing Skin Cancer in Organ Transplant Recipients
Nindl, I., & Rösl, F. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02392.x · Cited by 61
Vojtěchová, Z., Sabol, I., Saláková, M., Turek, L. P., Grega, M., Šmahelová, J., Vencálek, O., Lukešová, E., Klozar, J., & Tachezy, R. (2015) · International Journal of Cancer · doi:10.1002/ijc.29712 · Cited by 61
Westrich, J. A., Warren, C. J., Klausner, M. J., Guo, K., Liu, C.-W., Santiago, M. L., & Pyeon, D. (2018) · Journal of Virology · doi:10.1128/jvi.01318-17 · Cited by 60
Human Papillomavirus 45 Genetic Variation and Cervical Cancer Risk Worldwide
Chen, A. A., Heideman, D. A. M., Boon, D., Gheit, T., Snijders, P. J. F., Tommasino, M., Franceschi, S., & Clifford, G. M. (2014) · Journal of Virology · doi:10.1128/jvi.03534-13 · Cited by 59
Self-citationKabsch, K., Mossadegh, N., Kohl, A., Komposch, G., Schenkel, J., Alonso, A., & Tomakidi, P. (2004) · Intervirology · doi:10.1159/000076642 · Cited by 58
Hampras, S. S., Rollison, D. E. M., Giuliano, A. R., McKay‐Chopin, S., Minoni, L., Sereday, K. A., Gheit, T., & Tommasino, M. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix245 · Cited by 58
Self-citationRole of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination
Mortensen, F., Schneider, D., Barbic, T., Sladewska-Marquardt, A., Kühnle, S., Marx, A., & Scheffner, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505923112 · Cited by 57
Cited by
Bell, M., Verberckmoes, B., Devolder, J., Vermandere, H., Degomme, O., Guimarães, Y. M., Godoy, L. R., Ambrosino, E., Cools, P., & Padalko, E. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00081-23 · Cited by 22
“HPV is a small, nonenveloped DNA virus, possessing the ability to infect cutaneous or mucosal surfaces (3).”
BackgroundMaternal HPV Infection and the Estimated Risks for Adverse Pregnancy Outcomes—A Systematic Review
Popescu, S. D., Boiangiu, A. G., Sima, R.-M., Bilteanu, L., Vladareanu, S., & Vladareanu, R. (2022) · Diagnostics · doi:10.3390/diagnostics12061471 · Cited by 17
Metadata
- Authors
- Gheit, T.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-05-08
- Volume
- 9
- Pages
- 355-355
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2944746248
- Cited by
- 325
- References
- 271
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.